Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.

Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)

Sunday Q & A (2017 Conference) (LDN, low dose naltrexone)

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

A Non-Invasive First Approach Toward Idiopathic Female Infertility - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Wiebke Pape, MD - A Medication to Gain Self-Awareness: Treatment of Dissociative Symptoms in Trauma-Related Disorder II (2017 Conference) (LDN, low dose naltrexone)

Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)

Angus Dalgleish, MD - The Role of Non-Cytotoxic Drugs in the Management of Cancer (2017 Conference) (LDN, low dose naltrexone)